Speaker Abstracts
All abstracts are in PDF format.
- Hilary Calvert (University College London)
-
Clinical Development of Carboplatin: Succeeding Slowly is Better than Failing Fast
- Michael Cleare (Skysong Innovations)
-
Serendipity, Persistence and Innovative Clinicians: Comments on the Research, Development and Approval of Carboplatin
- Matthew Hall (NIH)
-
The Pre-History and Future of Platinum Anticancer Drugs
- James Hoeschele (Eastern Michigan University)
-
Discovery of the Antitumor Activity of Cisplatin: Participants, Events and Impact
- Stephen Lippard (MIT)
-
Understanding and Improving Cisplatin
- Bernhard Lippert (Technische Universität Dortmund)
-
Working with Barnett Rosenberg: A Personal Appreciation of my Postdoctoral Time at MSU and on an Exciting Project, the Platinum Pyrimidine Blue
- Sophia Lunt (MSU)
-
Deciphering Metabolic Rewiring in Cancer
- Anna Moore (MSU)
-
Precision Nanomedicine in Cancer Therapy
- Franco Muggia (NYU)
-
Platinums, BRCA Mutations, Impaired DNA Repair: Factors in the Cure of Women’s Cancer
- Jetze Tepe (MSU)
-
Therapeutic Applications of Small Molecule Proteasome Activation